Reply to Venda Nova et al.

Abstract

We thank Venda Nova et al. 7 for their interest in our work. We fully agree that trigeminal neuralgia (TN), despite being a rare disorder, is a syndrome that would benefit from a joint effort from healthcare providers and patients to develop and validate outcome measurements that are comprehensive, relevant, and comprehensible for end users.